CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19

INTRO: With the first case of COVID-19 in Cuba on March 11, 2020, the Center for Genetic Engineering and Biotechnology in Havana began an extensive vaccine program. Two vaccines based on RBD recombinant protein were developed, one for systemic administration “Abdala” and one mucosal vaccine “Mambisa...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillen, G., Limonta, M., Muzio, V., Lemos, G., Hernández-Bernal, F., Chinea, G., Gonzalez-Roche, D., Martin, A., Bequet, M., Marques, G., Zamora, J., Brito, J., Enriquez-Puertas, J., Cruz-Sui, O., Noa, E., Gonzalez-Sosa, N., Dubed, M., Valdibia, I., Palenzuela, A., Valdes, J., Carlos-Pia, N., Rodriguez, M., Ayala, M., Pimentel, E., Martinez, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Oral Session 3: Vaccines DevelopmentsDate: Saturday, Nov 19, 2022 Time: 8:00-9:00Venue: Banquet Hall
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186873/
http://dx.doi.org/10.1016/j.ijid.2023.04.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186873/
http://dx.doi.org/10.1016/j.ijid.2023.04.027

Ejemplares similares